Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial
- PMID: 30266608
- DOI: 10.1016/j.jacc.2018.09.006
Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial
Abstract
Background: Patients with angina symptoms and/or signs of ischemia but no obstructive coronary artery disease (INOCA) pose a diagnostic and therapeutic challenge.
Objectives: The purpose of this study was to test whether an interventional diagnostic procedure (IDP) linked to stratified medicine improves health status in patients with INOCA.
Methods: The authors conducted a randomized, controlled, blinded clinical trial of stratified medical therapy versus standard care in patients with angina. Patients with angina undergoing invasive coronary angiography (standard care) were recruited. Patients without obstructive CAD were immediately randomized 1:1 to the intervention group (stratified medical therapy) or the control group (standard care, IDP sham procedure). The IDP consisted of guidewire-based assessment of coronary flow reserve, index of microcirculatory resistance, fractional flow reserve, followed by vasoreactivity testing with acetylcholine. The primary endpoint was the mean difference in angina severity at 6 months (assessed by the Seattle Angina Questionnaire summary score).
Results: A total of 391 patients were enrolled between November 25, 2016, and November 12, 2017. Coronary angiography revealed obstructive disease in 206 (53.7%). One hundred fifty-one (39%) patients without angiographically obstructive CAD were randomized (n = 76 intervention group; n = 75 blinded control group). The intervention resulted in a mean improvement of 11.7 U in the Seattle Angina Questionnaire summary score at 6 months (95% confidence interval [CI]: 5.0 to 18.4; p = 0.001). In addition, the intervention led to improvements in the mean quality-of-life score (EQ-5D index 0.10 U; 95% CI: 0.01 to 0.18; p = 0.024) and visual analogue score (14.5 U; 95% CI: 7.8 to 21.3; p < 0.001). There were no differences in major adverse cardiac events at the 6-month follow-up (2.6% controls vs. 2.6% intervention; p = 1.00).
Conclusions: Coronary angiography often fails to identify patients with vasospastic and/or microvascular angina. Stratified medical therapy, including an IDP with linked medical therapy, is routinely feasible and improves angina in patients with no obstructive CAD. (CORonary MICrovascular Angina [CorMicA]; NCT03193294).
Keywords: INOCA; elective coronary angiography; microvascular angina; stable angina pectoris; stratified medical therapy; vasospastic angina.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Invasive Functional Test in Patients With Angina and Suspected CAD: Search More to Learn More.J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2856-2858. doi: 10.1016/j.jacc.2018.10.010. J Am Coll Cardiol. 2018. PMID: 30522648 No abstract available.
Similar articles
-
1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA).JACC Cardiovasc Interv. 2020 Jan 13;13(1):33-45. doi: 10.1016/j.jcin.2019.11.001. Epub 2019 Nov 11. JACC Cardiovasc Interv. 2020. PMID: 31709984 Free PMC article. Clinical Trial.
-
Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study.Am Heart J. 2020 Mar;221:48-59. doi: 10.1016/j.ahj.2019.11.015. Epub 2019 Dec 2. Am Heart J. 2020. PMID: 31911341 Free PMC article.
-
Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.Circ Cardiovasc Interv. 2019 Dec;12(12):e008126. doi: 10.1161/CIRCINTERVENTIONS.119.008126. Epub 2019 Dec 13. Circ Cardiovasc Interv. 2019. PMID: 31833416 Free PMC article.
-
Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial.Am Heart J. 2018 Jul;201:86-94. doi: 10.1016/j.ahj.2018.03.010. Epub 2018 Apr 3. Am Heart J. 2018. PMID: 29803987 Free PMC article. Review.
-
How to Diagnose and Manage Angina Without Obstructive Coronary Artery Disease: Lessons from the British Heart Foundation CorMicA Trial.Interv Cardiol. 2019 May 21;14(2):76-82. doi: 10.15420/icr.2019.04.R1. eCollection 2019 May. Interv Cardiol. 2019. PMID: 31178933 Free PMC article. Review.
Cited by
-
Thrombolysis in Myocardial Infarction Frame Count for Coronary Blood Flow Evaluation during Interventional Diagnostic Procedures.Medicina (Kaunas). 2023 Dec 15;59(12):2185. doi: 10.3390/medicina59122185. Medicina (Kaunas). 2023. PMID: 38138288 Free PMC article.
-
MINOCA: One Size Fits All? Probably Not-A Review of Etiology, Investigation, and Treatment.J Clin Med. 2022 Sep 20;11(19):5497. doi: 10.3390/jcm11195497. J Clin Med. 2022. PMID: 36233366 Free PMC article. Review.
-
Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries.J Am Heart Assoc. 2023 Jan 3;12(1):e027664. doi: 10.1161/JAHA.122.027664. Epub 2022 Dec 24. J Am Heart Assoc. 2023. PMID: 36565193 Free PMC article.
-
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA).Front Cardiovasc Med. 2021 Nov 17;8:781485. doi: 10.3389/fcvm.2021.781485. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34869695 Free PMC article. Review.
-
Myocardial Microvascular Physiology in Acute and Chronic Coronary Syndromes, Aortic Stenosis, and Heart Failure.J Interv Cardiol. 2022 Jan 26;2022:9846391. doi: 10.1155/2022/9846391. eCollection 2022. J Interv Cardiol. 2022. PMID: 35935124 Free PMC article. No abstract available.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous